Chris Raymond
Chris Raymond
matter meantime outcome volatility
It doesn't matter what the real outcome is for a long time. In the meantime we're going to see some volatility just on the headlines.
hard positively results revenue spin terms
Its hard to really spin these results positively in terms of the revenue mess.
bit blunt patients physicians struggle
I think you're going to see a bit of a struggle between patients and physicians going forward, which I think can blunt the near-term uptake of the drug.
hitting issue stock stride trade
I don't think they have an issue in the marketplace. Operationally, they're hitting their stride ... but this is a stock that has to trade on more near-term earnings.